Live Quote · NASDAQCCCCHealthcare· Biotechnology

C4 Therapeutics, Inc.

$2.48▲ 1.64%(+$0.04)
MKT CAP $325.67MNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
55/100
▌ Mixed
60
Valuation
40
Profitability
65
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CCCC research report →

Analyst Price Target
$7.00+182.3% vs. today

Range $7 – $7

Analyst RatingBuy
11 Buy3 Hold1 Sell

Price Chart

+4.20% · this period
$4.67$3.19$1.71Nov 20May 26Nov 20
52-Week Range23% of range
Low
$1.69
Current
$2.48
High
$5.17